Skip links

UCL boosts Biochemical Engineering Innovation Suite with BioSolve Process

Leading university installs Biopharm’s process modelling software on 50 systems in newly opened technology centre

Biopharm, the bioprocess analysis software developer, today announced that its BioSolve Process software tool has been installed on 50 workstations in the new Design Suite in the Department of Biochemical Engineering at University College London.

BioSolve Process will play an integral role in the department’s Undergraduate Training and Modular Training for the Bioprocess Industries Programme (MBI®), which comprises a series of UCL-accredited short courses in bioprocessing, designed specifically for industrialists that can be taken as stand-alone modules or can be combined for Certificate, Diploma or Masters Qualifications.

BioSolve Process is the biopharmaceutical industry’s leading process analysis and economic modelling package, providing insight that enables biopharma innovators to reduce manufacturing costs and make informed process decisions to improve profitability and ultimately patient access.

“We were determined that BioSolve Process should be part of our new Design Suite, as it is such a powerful tool for industry modelling, supplied and regularly updated with a massive amount of up-to-date industry information,” Professor Nigel Titchener Hooker, Head of Department, Department of Biochemical Engineering, University College London. “We are looking forward to working with the latest BioSolve for the undergraduate teaching programme and the MBI Programme to deliver compelling process design and economic evaluation modules to future and current industry participants.”

Unlike in-house modelling systems, BioSolve Process accesses the latest technologies and processes from across the biopharmaceutical sector to deliver impartial knowledge, allowing users to quickly carry out multiple process comparison analyses before making a commitment.

“We are delighted that UCL has chosen to include BioSolve Process in the Innovation Suite, and we look forward to participating in the MBI programme on an ongoing basis,” said Andrew Sinclair, CEO, Biopharm. “This is a huge validation of the comprehensive coverage provided by our software, which we are confident is the industry’s most powerful tool for bioprocess analysis.”

BioSolve Process 5 is also fully integrated with a central database for model, data and process management. The seamless integration with Biopharm’s enterprise application, BioSolve Connect, allows users to future proof their investment by sharing processes, facility information, cost data sets, unit operation models centrally.

About UCL’s Biochemical Engineering
The UCL Department of Biochemical Engineering is at the forefront of bioprocess research and is the largest centre in the UK. In the latest Research Assessment Exercise 75% of academic staff were rated as ‘world leading’ or ‘internationally excellent’. Our interdisciplinary Advanced Centre for Biochemical Engineering (ACBE) coordinates bioprocess research and training collaborations with more than a dozen UCL departments, a similar number of external university partners and over 40 international companies.

Over 75% of our research projects are collaborative with industry and all address strategically significant issues, frequently on a truly global scale. This close working relationship with industry provides unparalleled opportunities for our research teams to tackle long term problems with leaders in the sector and is a hallmark of the UCL approach.

About Biopharm
Biopharm was founded in December 1998 to develop technology solutions and services for the biopharmaceutical manufacturing business, covering biologic products, facilities and manufacturing strategy. The company is the developer of BioSolve, the biopharmaceutical industry’s most powerful set of bioprocess analysis tools. The BioSolve product range enables biopharma innovators to reduce manufacturing costs and make informed process decisions to improve profitability and ultimately patient access.